Companies: 10,795·Total market cap: $144.5T
AnPac Bio-Medical Science Co., Ltd.

AnPac Bio-Medical Science Co., Ltd.

ANPCNASDAQHealthcare
$4.30
$-0.14(-3.15%)
Market Cap$26974846
P/E Ratio
52W High$11.99
52W Low$2.6

AnPac Bio-Medical Science Co., Ltd. (ANPC) Revenue

Annual & quarterly revenue history · segment & region breakdown

ANPC · revenue · updated Jun 9, 2026

Core revenue metrics

AnPac Bio-Medical Science Co., Ltd. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.01B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
2.24×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$135K
89 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · AnPac Bio-Medical Science Co., Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
ANPC revenue by year · ANPC revenue history · ANPC annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income AnPac Bio-Medical Science Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

AnPac Bio-Medical Science Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from AnPac Bio-Medical Science Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

ANPC revenue · 4 questions

ANPC's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.

ANPC revenueANPC annual revenuewhat is ANPC revenueANPC TTM revenue

Source: FMP · AnPac Bio-Medical Science Co., Ltd. SEC filings · GAAP · AnPac Bio-Medical Science Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026